106 patients with CF were prospectively included in the present study and received ARFI-imaging of the left and right liver-lobe, ARFI of the pancreas TE of the liver and laboratory evaluation.
The prevalence of liver-fibrosis according to recently published best practice guidelines for CFLD was 22.6 % . Prevalence of significant liver-fibrosis assessed by TE, ARFI-right-liver-lobe, ARFI-left-liver-lobe, Fibrotest, Fibrotest-corrected-by-haptoglobin was 17 % , 24 % , 40 % , 7 % , and 16 % , respectively. The best agreement was found for TE, ARFI-right-liver-lobe and Fibrotest-corrected-by-haptoglobin. Patients with pancreatic-insufficiency had significantly lower pancreas-ARFI-values as compared to patients without.
ARFI-imaging and TE seem to be promising non-invasive methods for detection of liver-fibrosis in patients with CF.